CP
GEHC icon

Castleview Partners’s GE HealthCare GEHC Stock Holding History

Castleview Partners’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,007
Closed -$214K – 234
2026
Q1 		$214K Buy
+3,007
New +$237K 0.11% 181
2025
Q1 		– Sell
-698
Closed -$54.7K – 324
2024
Q4 		$54.7K Buy
698
+335
+92% +$28.5K 0.03% 330
2024
Q3 		$34.1K Buy
363
+6
+2% +$504 0.02% 380
2024
Q2 		$27.8K Buy
357
+10
+3% +$816 0.02% 400
2024
Q1 		$31.5K Buy
347
+188
+118% +$15.6K 0.02% 407
2023
Q4 		$12.3K Buy
159
+78
+96% +$5.46K 0.01% 496
2023
Q3 		$5.51K Hold
81
– – 0.01% 475
2023
Q2 		$6.58K Hold
81
– – 0.01% 476
2023
Q1 		$6.64K Buy
+81
New +$5.78K 0.01% 466

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Castleview Partners's GEHC Position: Q2 2026 in Review

Castleview Partners sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 3,007 shares — an estimated $214K sold.

Castleview Partners first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $214K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Castleview Partners reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Castleview Partners sold 3,007 GE HealthCare shares in Q2 2026, an estimated $214K.
  • Castleview Partners first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Castleview Partners's GE HealthCare position peaked at $214K in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.